Effectiveness and safety of intravenous
β
Justin L Kaplan; John A Marx
π
Article
π
1993
π
Elsevier Science
π
English
β 408 KB
Study objective: To evaluate the efficacy and safety of nalmefene, an investigational narcotic antagonist that has potential advantages over naloxone because of its four-to eight-hour halflife, in emergency department patients with possible narcotic overdose.